Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 7, 2009
J Am Soc Nephrol 21: 209-211, 2010
© 2010 American Society of Nephrology
doi: 10.1681/ASN.2008080899
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008080899v1
21/2/209    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Winchester, J. F.
Right arrow Articles by Ronco, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winchester, J. F.
Right arrow Articles by Ronco, C.

Clinical Commentary

Sorbent Augmented Hemodialysis Systems: Are We There Yet?

James F. Winchester* and Claudio Ronco{dagger}

*Department of Clinical Medicine, Albert Einstein College of Medicine, Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, New York; and
{dagger}Department of Medicine, University of Padua, Division of Nephrology and Renal Transplantation, San Bortolo Hospital, Vicenza, Italy

Correspondence: Dr. James F. Winchester, Division of Nephrology & Hypertension, Beth Israel Medical Center, 350 17th Street, 18BH20, New York, NY 10003. Phone: 212-420-4070; Fax: 212-420-4117; E-mail: jwinches{at}bethisraelny.org

Recent publications have reintroduced the concept of using sorbent systems to augment the efficiency of the dialysis process, either by making stationary or compact wearable devices to regenerate dialysis fluid or to target larger molecules for removal by direct blood or plasma contact with sorbent particles. Many of the inherent problems associated with older sorbents have been overcome by designing sorbents with improved biocompatibility and potential for removing molecules beyond the limits of conventional dialysis membranes. One system is approved for use in acute renal failure in the United States, but other devices are not approved for use in humans and continue to be tested in animals and humans. A prototype wearable sorbent device under investigation is not yet able to meet acceptable small molecular weight solute removal, and the other sorbent devices that possess the ability to remove unconventional uremic toxins have not been studied sufficiently in dialysis patients to define their role as augmentation devices. That there is a renewal of interest in sorbents in augmentation of dialysis points to the dissatisfaction with current dialysis technology.






HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673